KR840003419A - Method of manufacturing human immune response inhibitory factor - Google Patents

Method of manufacturing human immune response inhibitory factor Download PDF

Info

Publication number
KR840003419A
KR840003419A KR1019830000414A KR830000414A KR840003419A KR 840003419 A KR840003419 A KR 840003419A KR 1019830000414 A KR1019830000414 A KR 1019830000414A KR 830000414 A KR830000414 A KR 830000414A KR 840003419 A KR840003419 A KR 840003419A
Authority
KR
South Korea
Prior art keywords
human cells
hirs
human
cells
animal
Prior art date
Application number
KR1019830000414A
Other languages
Korean (ko)
Other versions
KR900005860B1 (en
Inventor
가나메 스기모도
Original Assignee
하야시바라 껭
가부시기 가이샤 하야시바라 세이부쓰 가가꾸 껭뀨우죠
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 하야시바라 껭, 가부시기 가이샤 하야시바라 세이부쓰 가가꾸 껭뀨우죠 filed Critical 하야시바라 껭
Publication of KR840003419A publication Critical patent/KR840003419A/en
Application granted granted Critical
Publication of KR900005860B1 publication Critical patent/KR900005860B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Microbiology (AREA)
  • Transplantation (AREA)
  • General Engineering & Computer Science (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

내용 없음No content

Description

인간의 면역응답 억제인자의 제조방법Method of manufacturing human immune response inhibitory factor

본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음As this is a public information case, the full text was not included.

Claims (12)

다음과 같은 단계들로 구성된 hIRS의 제조방법 :Manufacturing method of hIRS consisting of the following steps: (1) hIRS를 생산할 수 있는 인간세포들을 인간 이외의 은혈동물에 이식; 그 동물의 영양체액을 이용하여 인간세포들이 증식되도록 함; 그리고 증식된 인간세포들이 hIRS를 생산하도록 함, 또는 대안으로써,(1) transplanting human cells capable of producing hIRS to silver blood animals other than humans; Use the animal's nutrient fluids to allow human cells to proliferate; And allowing proliferated human cells to produce hIRS, or alternatively, (2) hIRS를 생산할 수 있는 인간세포들을 인간 이외의 은혈동물의 영양체액이 인간세포들에 공급되도록 고안된 장치에 넣음; 그 체액을 이용하여 인간세포들이 증식되도록 함; 그리고 증식된 인간세포들이 hIRS를 생산하도록 함.(2) human cells capable of producing hIRS are placed in a device designed to supply nutrient fluids from silver blood animals other than humans to human cells; Use the body fluids to proliferate human cells; And proliferated human cells to produce hIRS. 제1항에 있어서, 다음과 같이 구성된 방법 :The method of claim 1 consisting of: (1) hIRS를 생산할 수 있는 인간세포들을 인간 이외의 은혈동물에 이식; 인간세포들이 그 동물의 영양체액을 이용하여 증식되도록 그 동물을 사육; 그 동물내에 형성된 종양을 적출하고 분산하여 증식된 인간세포들을 얻음; 상당량의 hIRS가 최적되기에 충분한 기간동안 IRS 유도체의 존재 또는 부재하에 시험관내의 영양배지에서 그 인간세포들을 배양; 배지로 부터 축적된 hIRS를 채취, 또는 대안으로써,(1) transplanting human cells capable of producing hIRS to silver blood animals other than humans; Breeding the animal so that human cells multiply using the animal's nutrient fluids; Extracting and dispersing tumors formed in the animal to obtain proliferated human cells; Culturing the human cells in in vitro nutrient medium in the presence or absence of an IRS derivative for a period of time sufficient for a significant amount of hIRS to be optimal; Collecting hIRS from the medium, or as an alternative, (2) hIRS를 생산할 수 있는 인간세포들의 현탁액을 인간 이외의 온혈동물의 영양체액이 상기의 인간세포들에 공급되는 종래의 형태의 확산실에 넣음; 그 확산실을 인간 이외의 온혈동물내 또는 위에 삽입 또는 놓음; 인간세포들이 그 체액을 이용하여 증식되도록 그 동물을 사육; 확산실로 부터 증식된 인간세포들을 수집; 상당량의 hIRS가 축적되기에 충분한 기간동안 IRS 유도제의 존재 또는 부재하에 시험관내의 영양배지에서 그 인간세포들을 배양; 배지로 부터 축적된 hIRS를 채취.(2) placing a suspension of human cells capable of producing hIRS into a conventional type diffusion chamber in which nutrient fluids from warm-blooded animals other than humans are supplied to the human cells; Inserting or placing the diffusion chamber in or on a warm-blooded animal other than a human; Raising the animal so that human cells multiply using the body fluid; Collecting human cells proliferated from the diffusion chamber; Culturing the human cells in nutrient media in vitro in the presence or absence of an IRS inducer for a period sufficient to accumulate a significant amount of hIRS; Collected hIRS from the medium. 제1항에 있어서, hIRS를 생산할 수 있는 상기의 인간세포들이 말초혈, 비장세포들 및 편도세포로 구성된 그룹으로 부터 선택된 정상적인 인간세포들인 방법.The method of claim 1, wherein said human cells capable of producing hIRS are normal human cells selected from the group consisting of peripheral blood, splenocytes, and tonsil cells. 제1항에 있어서, 상기의 인간세포들이 인간의 편도종양세포들, 간암세포들, 비장종양세포들, 폐암세포들 및 제3항에 기승된 인간세포들을 변형함으로써 얻을 수 있는 것들로 구성된 그룹으로 부터 선택된 인간의 종양세포들인 방법.According to claim 1, wherein the human cells are a group consisting of human tonsil tumor cells, liver cancer cells, spleen tumor cells, lung cancer cells and those obtainable by modifying the human cells inherited in claim 3 Which is selected from human tumor cells. 제1항에 있어서, 상기의 인간세포들이 hIRS 생산능이 도입된 잡종세포들인 방법.The method of claim 1, wherein the human cells are hybrid cells introduced hIRS production capacity. 제1항에 있어서, 상기의 인간세포들이 hIRS 생산능을 도입하기 위해 제4항 및 제5항에 기승된 인간 세포들중 어떠한 것으로 잡종화된 인간의 임파아구 세포(human lymphoblastoid line)인 방법.The method of claim 1, wherein said human cells are human lymphoblastoid lines hybridized with any of the human cells inherited in claims 4 and 5 to introduce hIRS production capacity. 제6항에 있어서, 상기의 인간의 임파아구 세포가 나말와(Namalwa), BALL-1, NALL-1, TAIL-1 및 JBL로 구성된 그룹으로 부터 선택된 멤버인 방법.7. The method of claim 6, wherein said human lymphoblast cells are members selected from the group consisting of Namalwa, BALL-1, NALL-1, TAIL-1 and JBL. 제1항에 있어서, 상기의 인간 이외의 온혈동물이 포유류 또는 조류인 방법.The method of claim 1, wherein the warm-blooded animal other than human is a mammal or a bird. 제2항에 있어서, 상기의 IRS 유도제가 유사분열물질(mitogen), 비루스, 및 헥산으로 구성된 그룹으로 부터 선택된 하나 또는 그 이상의 멤버들인 방법.The method of claim 2, wherein said IRS inducer is one or more members selected from the group consisting of mitogen, virus, and hexane. hIRS를 생산할 수 있는 인간세포들의 증식, 그리고 상당량의 hIRS가 축적되기에 충분한 기간동안 IRS 유도제의 존재 또는 부재하에 증식된 인간세포들의 배양을 포함하는 hIRS의 제조방법에 있어서, 세포증식율과 hIRS 생산량을 극히 증가시키는 다음과 같은 방법 :In the method of producing hIRS including the proliferation of human cells capable of producing hIRS, and the culturing of human cells grown in the presence or absence of an IRS inducer for a period of time sufficient to accumulate a significant amount of hIRS, cell proliferation rate and hIRS production The following ways to increase dramatically: (1) hIRS를 생산할 수 있는 인간세포들을 인간 이외의 온혈동물에 이식; 그 동물의 영양체액을 이용하여 인간세포들이 증식되도록 그 동물을 사육; 증식된 인간세포들을 얻기위해 그 동물내에 형성된 종양을 적출 그리고 분산; 상당량의 hIRS가 축적되기에 충분한 기간동안 IRS 유도제의 존재 또는 부재하에 시험관내의 영양배지에서 인간세포들을 배양; 그리고 배지로 부터 축적된 hIRS를 채취, 또는 대안으로써,(1) transplanting human cells capable of producing hIRS into warm blooded animals other than humans; Breeding the animal to proliferate human cells using the animal's nutrient fluid; Extracting and dispersing tumors formed in the animal to obtain expanded human cells; Culturing human cells in nutrient medium in vitro with or without IRS inducer for a period sufficient to accumulate a significant amount of hIRS; And collecting, or alternatively, hIRS accumulated from the medium, (2) hIRS를 생산할 수 있는 인간세포들의 현탁액을 영양체액이 상기의 인간세포들에 공급되는 종래의 형태의 확산실에 넣음; 그 확산실을 인간 이외의 온혈동물내 또는 위에 삽입 또는 놓음; 인간세포들이 체액을 이용하여 증식되도록 그 동물을 사육; 확산실로 부터 증식된 인간세포들을 수집; 상당량의 hIRS가 축적되기에 충분한 기간동안 hIRS 유도체의 존재 또는 부재하에 시험관내의 영양배지에서 인간세포들을 배양; 그리고 배지로 부터 축적된 hIRS를 채취.(2) placing a suspension of human cells capable of producing hIRS into a conventional type diffusion chamber in which nutrient solution is supplied to said human cells; Inserting or placing the diffusion chamber in or on a warm-blooded animal other than a human; Breeding the animal such that human cells proliferate using body fluids; Collecting human cells proliferated from the diffusion chamber; Culturing human cells in nutrient media in vitro in the presence or absence of hIRS derivatives for a period of time sufficient to accumulate a significant amount of hIRS; And collecting accumulated hIRS from the medium. 실시예들 중 어떠한 것에 실질적으로 기승된 hIRS의 제조방법.A method of making hIRS carried substantially on any of the embodiments. 제1항에 기승된 방법에 의해 제조된 hIRS.HIRS prepared by the process according to claim 1. ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.※ Note: The disclosure is based on the initial application.
KR1019830000414A 1982-02-12 1983-02-03 Process for producing human immune response suppresor KR900005860B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP82-19560 1982-02-12
JP57019560A JPS58138395A (en) 1982-02-12 1982-02-12 Production of human immune response suppression (hirs) factor

Publications (2)

Publication Number Publication Date
KR840003419A true KR840003419A (en) 1984-09-08
KR900005860B1 KR900005860B1 (en) 1990-08-13

Family

ID=12002686

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019830000414A KR900005860B1 (en) 1982-02-12 1983-02-03 Process for producing human immune response suppresor

Country Status (6)

Country Link
JP (1) JPS58138395A (en)
KR (1) KR900005860B1 (en)
CH (1) CH661745A5 (en)
FR (1) FR2521588B1 (en)
GB (1) GB2118560B (en)
IT (1) IT1167074B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS609795B2 (en) * 1980-12-11 1985-03-13 株式会社林原生物化学研究所 Method for producing human epidermal growth factor
JPS63126897A (en) * 1986-05-02 1988-05-30 Yoshitomi Pharmaceut Ind Ltd Immunosuppressive factor

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2016015B (en) * 1978-01-22 1982-05-06 Hayashibara Co Method of preparing interferon and preparations containing interferon
JPS5729294A (en) * 1980-07-30 1982-02-17 Hayashibara Biochem Lab Inc Preparation of human insulin
JPS6045848B2 (en) * 1980-07-31 1985-10-12 株式会社林原生物化学研究所 Method for producing human growth hormone

Also Published As

Publication number Publication date
IT8347689A0 (en) 1983-02-10
FR2521588B1 (en) 1985-10-25
JPH0214038B2 (en) 1990-04-05
GB8303870D0 (en) 1983-03-16
CH661745A5 (en) 1987-08-14
GB2118560A (en) 1983-11-02
FR2521588A1 (en) 1983-08-19
KR900005860B1 (en) 1990-08-13
GB2118560B (en) 1985-06-05
JPS58138395A (en) 1983-08-17
IT1167074B (en) 1987-05-06

Similar Documents

Publication Publication Date Title
Sawamoto et al. Visualization, direct isolation, and transplantation of midbrain dopaminergic neurons
KR860001588B1 (en) Process for the production of human epidermal growth factor
Sugiyama et al. Embryonic regulation of the mouse hematopoietic niche
EP2638798B1 (en) Method for the culture and mass micropropagation of deschampsia antarctica in vitro
Polvsen Heterotransplantation of human malignant melanomas to the mouse mutant nude
Starr Relative Amounts of Vitamin B" 12" in Detritus from Oceanic and Estuarine Environments Near Sapelo Island, Georgia
JPS57206384A (en) Cultivating method of cell
KR840003419A (en) Method of manufacturing human immune response inhibitory factor
JPS5852634B2 (en) Production method of urokinase
KR850004271A (en) New Lymphokine and its monotrophic native antibody preparation method
Thomson Controlled growth en masse (somatic growth) of embryonic chick tissue in vitro
Vasantha et al. Influence of music on the growth of koi carp, Cyprinus carpio (Pisces: Cyprindae)
Gui-Hwan et al. A study on seedling production of Jicon scallop, Chlamys farreri 1. Spawning, Development and rearing of larvae
KR860001576B1 (en) Process for the production of human multiplication-stimulating activity
KR840003287A (en) Method of manufacturing human kallikrein
JPS6030656B2 (en) Method for producing human T cell growth factor
KR860001591B1 (en) Process for the production of human adrenocorticotropic hormone
CN2177337Y (en) Three-dimensional intensive culturing device for young and grown crabs
RO132898A2 (en) Incubation installation for reproduction of sturgeons bred in recycled water systems, even in the off season
CN113637636B (en) Method for improving initial T cell proportion of in-vitro culture
Robinson The behaviour and morphology of human oesophageal carcinoma cells in vivo and in vitro and a comparison with the normal.
Kakinuma Life cycle of a hydrozoan, Sarsia tubulosa (Sars)
JPS57115180A (en) Preparation of human tyroid-stimulating hormone
KR900018379A (en) Method for producing cancer metastasis suppressor
TWI224135B (en) Method of Helminthocladia australis for producing high OD phycoerythrin

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 19960730

Year of fee payment: 7

LAPS Lapse due to unpaid annual fee